Literature DB >> 25098537

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.

Ishu Arpan1, Rebecca J Willcocks1, Sean C Forbes1, Richard S Finkel1, Donovan J Lott1, William D Rooney1, William T Triplett1, Claudia R Senesac1, Michael J Daniels1, Barry J Byrne1, Erika L Finanger1, Barry S Russman1, Dah-Jyuu Wang1, Gihan I Tennekoon1, Glenn A Walter1, H L Sweeney1, Krista Vandenborne2.   

Abstract

OBJECTIVE: To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS).
METHODS: Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls.
RESULTS: Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation.
CONCLUSIONS: These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25098537      PMCID: PMC4162304          DOI: 10.1212/WNL.0000000000000775

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.

Authors:  Hermien E Kan; Tom W J Scheenen; Marielle Wohlgemuth; Dennis W J Klomp; Ivonne van Loosbroek-Wagenmans; George W Padberg; Arend Heerschap
Journal:  Neuromuscul Disord       Date:  2009-03-28       Impact factor: 4.296

2.  Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis.

Authors:  J Phoenix; D Betal; N Roberts; T R Helliwell; R H Edwards
Journal:  Muscle Nerve       Date:  1996-03       Impact factor: 3.217

3.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging.

Authors:  Franklin A Marden; Anne M Connolly; Marilyn J Siegel; David A Rubin
Journal:  Skeletal Radiol       Date:  2004-10-22       Impact factor: 2.199

Review 4.  Role of proton MR for the study of muscle lipid metabolism.

Authors:  Chris Boesch; Juergen Machann; Peter Vermathen; Fritz Schick
Journal:  NMR Biomed       Date:  2006-11       Impact factor: 4.044

5.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.

Authors:  Tishya A L Wren; Stefan Bluml; Linda Tseng-Ong; Vicente Gilsanz
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

6.  Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.

Authors:  J T Kissel; D J Lynn; K W Rammohan; J P Klein; R C Griggs; R T Moxley; V A Cwik; M H Brooke; J R Mendell
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

7.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

Authors:  B J Petrof; J B Shrager; H H Stedman; A M Kelly; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy.

Authors:  Y Huang; S Majumdar; H K Genant; W P Chan; K R Sharma; P Yu; M Mynhier; R G Miller
Journal:  J Magn Reson Imaging       Date:  1994 Jan-Feb       Impact factor: 4.813

Review 9.  Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

Authors:  A Y Manzur; T Kuntzer; M Pike; A Swan
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Deflazacort in Duchenne dystrophy: study of long-term effect.

Authors:  C Angelini; E Pegoraro; E Turella; M T Intino; A Pini; C Costa
Journal:  Muscle Nerve       Date:  1994-04       Impact factor: 3.217

View more
  52 in total

Review 1.  MR Imaging of the Musculoskeletal System Using Ultrahigh Field (7T) MR Imaging.

Authors:  Hamza Alizai; Gregory Chang; Ravinder R Regatte
Journal:  PET Clin       Date:  2018-10

2.  Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.

Authors:  Abhinandan Batra; Ravneet S Vohra; Steve M Chrzanowski; David W Hammers; Donovan J Lott; Krista Vandenborne; Glenn A Walter; Sean C Forbes
Journal:  J Appl Physiol (1985)       Date:  2019-04-04

Review 3.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 4.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

5.  Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.

Authors:  Ravneet Vohra; Abhinandan Batra; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Am J Pathol       Date:  2017-09       Impact factor: 4.307

6.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

7.  Walking activity in a large cohort of boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Tanja Taivassalo; Claudia R Senesac; Rebecca J Willcocks; Ann M Harrington; Kirsten Zilke; Hilary Cunkle; Catherine Powers; Erika L Finanger; William D Rooney; Gihan I Tennekoon; Krista Vandenborne
Journal:  Muscle Nerve       Date:  2020-11-27       Impact factor: 3.217

8.  Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.

Authors:  R J Willcocks; W T Triplett; S C Forbes; H Arora; C R Senesac; D J Lott; T R Nicholson; W D Rooney; G A Walter; K Vandenborne
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

9.  Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.

Authors:  Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Radiology       Date:  2020-04-14       Impact factor: 11.105

10.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.